Medmain inc.

All

All Media(29) News(65) Press Release(31)

2024.09.12 | News

Notice of Acquisition of a First-Class Marketing License for Medical Devices
2024.09.04 | News

【Announcement of Participation in the 8th Digital Pathology & AI Congress Asia 2024】
2024.03.11 | News

We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups
2024.02.27 | News

Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo
2023.12.11 | News

We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Vietnam!
2023.12.07 | News

Notice of New Year Holidays
2023.11.07 | News

【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】
2023.10.31 | News

【Announcement of Participation in the “Viet Nam – Japan Medical ICT and Aging Workshop” hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】
2023.09.13 | Media

Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
2023.08.03 | News

The Ambassador of the United Arab Emirates visited our office!
2023.05.23 | Media

Successful Development of Artificial Intelligence to Enable Classification of Cutaneous Melanoma in a Whole Slide Image of Dermatopathology ~ Published in Cancers
2023.05.19 | Media

Successful Development of Artificial Intelligence to Enable Detection of Prostate Cancer for Surveillance and Radical Treatment -Published in BMC Cancer-
2023.04.03 | Media

Successful Development of Artificial Intelligence to Infer Histological Views From Whole Slide Images and Generate Them Into Text – Published in Proceedings of Machine Learning Research –
2023.03.27 | Media

Successful Development of Pathology AI to Classify Suspected Urothelial Carcinoma Lesions – Published in Cancers / Special Issue: Artificial Intelligence in Cancer Screening –
2023.02.22 | Media

【Successful Development of Pathology AI】Now Possible to Classify Gastric Poorly Differentiated Adenocarcinoma – Published in “Technology in Cancer Research & Treatment”
2023.02.13 | News

PidPort crossed the ocean and was introduced to international participants at Arab Health 2023
2023.01.31 | News

Our CEO Iizuka Osamu accompanied Mr. Nishimura Yasutoshi, Minister of Economy, Trade and Industry, to the UAE and participated in the ministerial meeting for signing “the Japan-UAE Coordination Scheme for Advanced Technology (JU-CAT)”.
2023.01.24 | News

【Announcement of Exhibition Participation】 Arab Health 2023
2023.01.17 | Media

【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Adenocarcinoma in Multiple Organs – Published in PLOS ONE
2023.01.17 | News

Osamu Iizuka, CEO of Medmain Inc., exchanged opinions with the US Ambassador to Japan Rahm Emanuel!
2022.12.13 | News

Notice of New Year Holidays

News

Notice of Acquisition of a First-Class Marketing License for Medical Devices

【Announcement of Participation in the 8th Digital Pathology & AI Congress Asia 2024】

We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups

Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo

We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Vietnam!

Notice of New Year Holidays

【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】

【Announcement of Participation in the “Viet Nam – Japan Medical ICT and Aging Workshop” hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】

Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech

The Ambassador of the United Arab Emirates visited our office!

Successful Development of Artificial Intelligence to Enable Classification of Cutaneous Melanoma in a Whole Slide Image of Dermatopathology ~ Published in Cancers

Successful Development of Artificial Intelligence to Enable Detection of Prostate Cancer for Surveillance and Radical Treatment -Published in BMC Cancer-

Successful Development of Artificial Intelligence to Infer Histological Views From Whole Slide Images and Generate Them Into Text – Published in Proceedings of Machine Learning Research –

Successful Development of Pathology AI to Classify Suspected Urothelial Carcinoma Lesions – Published in Cancers / Special Issue: Artificial Intelligence in Cancer Screening –

【Successful Development of Pathology AI】Now Possible to Classify Gastric Poorly Differentiated Adenocarcinoma – Published in “Technology in Cancer Research & Treatment”

PidPort crossed the ocean and was introduced to international participants at Arab Health 2023

Our CEO Iizuka Osamu accompanied Mr. Nishimura Yasutoshi, Minister of Economy, Trade and Industry, to the UAE and participated in the ministerial meeting for signing “the Japan-UAE Coordination Scheme for Advanced Technology (JU-CAT)”.

【Announcement of Exhibition Participation】 Arab Health 2023

【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Adenocarcinoma in Multiple Organs – Published in PLOS ONE

Osamu Iizuka, CEO of Medmain Inc., exchanged opinions with the US Ambassador to Japan Rahm Emanuel!

Notice of New Year Holidays